Recent advances in chronic pulmonary aspergillosis

Area of Science:

• Pulmonology
• Mycology
• Infectious Diseases

Background:

• Chronic pulmonary aspergillosis (CPA) is a progressive lung syndrome caused by Aspergillus species.
• There is a need for enhanced understanding of CPA's clinical presentation, diagnostic methods, and therapeutic strategies.

Purpose of the Study:

• To review recent advancements in the understanding of chronic pulmonary aspergillosis.
• To propose a new clinical entity encompassing chronic necrotizing and cavitary pulmonary aspergillosis.

Main Methods:

• Literature review focusing on recent publications concerning CPA.
• Analysis of accumulating evidence on CPA treatment and drug resistance.

Main Results:

• A new classification of chronic progressive pulmonary aspergillosis is proposed.
• Evidence supports longer azole administration for improved prognosis, but azole resistance is a concern.
• Therapeutic drug monitoring and patient education are essential for effective CPA management.

Conclusions:

• Further research is needed to address diagnostic and management challenges in CPA.
• Development of accessible drug-susceptibility testing is important.
• Translational research is urgently required to improve CPA patient outcomes.